Jorn Drappa

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Sanam Pangali, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jorn Drappa:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALUMIS INC. Chief Medical Officer Common Stock 28,450 $100,144 $3.52 29 Jul 2025 Direct
ALUMIS INC. Chief Medical Officer Stock Option (Right to Buy) 221,450 26 Jan 2026 Direct
Ventyx Biosciences, Inc. Chief Medical Officer Stock Option (right to buy) 145,000 04 Feb 2022 Direct
ALPINE IMMUNE SCIENCES, INC. Director Stock Option (Right to buy) 0 20 May 2024 Direct

Insider Reports Filed by Jorn Drappa

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALMS ALUMIS INC. 26 Jan 2026 1 $0 4 Chief Medical Officer 28 Jan 2026, 19:17
ALMS ALUMIS INC. 29 Jul 2025 2 $0 4 Chief Medical Officer 31 Jul 2025, 21:05
ALMS ALUMIS INC. 18 Feb 2025 1 $0 4 Chief Medical Officer 20 Feb 2025, 18:30
ALMS ALUMIS INC. 27 Jun 2024 17 $0 4 Chief Medical Officer 01 Jul 2024, 16:37
ALMS ALUMIS INC. 27 Jun 2024 0 $0 3 Chief Medical Officer 27 Jun 2024, 16:04
/report/000162619924000099-drappa-jorn-2024-05-20 ALPINE IMMUNE SCIENCES, INC. 20 May 2024 3 $0 4 Director 20 May 2024, 20:12
/report/000162619924000012-drappa-jorn-2024-01-02 ALPINE IMMUNE SCIENCES, INC. 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 19:05
/report/000162619923000019-drappa-jorn-2023-01-03 ALPINE IMMUNE SCIENCES, INC. 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 17:59
/report/000178931722000004-drappa-jorn-2022-07-18 ALPINE IMMUNE SCIENCES, INC. 18 Jul 2022 1 $0 4 Director 19 Jul 2022, 16:42
/report/000178931722000002-drappa-jorn-2022-07-18 ALPINE IMMUNE SCIENCES, INC. 18 Jul 2022 0 $0 3 Director 19 Jul 2022, 16:39
VTYX Ventyx Biosciences, Inc. 04 Feb 2022 1 $0 4 Chief Medical Officer 04 Feb 2022, 17:38
VTYX Ventyx Biosciences, Inc. 20 Oct 2021 0 $0 3 Chief Medical Officer 20 Oct 2021, 18:47
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .